Dr Reddy’s posts Q4 and FY17 financial results
In FY17, revenues were at Rs 140.8 billion and EBITDA at Rs 25.5 billion
Sign in
Sign in
Recover your password.
A password will be e-mailed to you.
GNH India clears Kenyan Pharmacy and Poison board audit
The company will export the first shipment of lifesaving drugs to Kenya shortly
Merck expands M Lab Collaboration Center in Bengaluru
The facility will provide biopharmaceutical manufacturers with a shared, exploratory environment where they can collaborate with…
Indoco receives UK-MHRA approval
This approval is the outcome of the inspection of Goa Plant I, which was conducted in December 2016
Bayer wins ‘Best Employer in India 2017’ Award
Study methodology involved a nine-month evaluation by an external panel of independent jury
Allow co-prescription of brands and generics: IDMA to PM
The association suggests that the government should abolish tax on all medicines and subsidise the price of medicines as is done…
US court rules in favour of Zydus Cadila in patent case
The US Court of Appeals for the Federal Circuit has affirmed judgement holding that Zydus Cadila's proposed generic version of…
Natco Pharma launches generic blood cancer drug in India
The company has priced its generic medicine of POMALID 1 mg, 2 mg, and 4 mg capsules at an MRP Rs 5,000, Rs 10,000 and Rs 20,000…
Allow co-prescription of brands and generic: IDMA to PM
Says branded and generics markets can complement and supplement each other
US FDA makes eight observations at Lupin’s Aurangabad unit
The inspection was completed on April 26, 2017